Abstract: The present invention, as described above and as further defined by the claims below, provides methods for forming an Ophthalmic Lens that encapsulates a Rigid Insert, wherein the Rigid Insert may be tailored to correct specific astigmatic characteristics of an eye and apparatus for implementing such methods, as well as Ophthalmic Lenses formed with the Rigid Inserts.
Type:
Grant
Filed:
February 12, 2019
Date of Patent:
March 9, 2021
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Randall B. Pugh, Daniel B. Otts, James D. Riall, Sharika Snook, Karson S. Putts, Edward R. Kernick, Frederick A. Flitsch, Camille Higham
Abstract: Tunable apodized multiple-focus ophthalmic devices and methods characterized by a lens with multiple optical zones each with an optical power optimized for one or more focal lengths and a tunable apodization mask positioned within at least a portion of the optical zone(s). Upon a desired change of focus for the wearer, an optical transmission characteristic of the tunable apodization mask may be varied. The tunable apodization mask may take the form of an electrochromic device or another suitable material.
Type:
Grant
Filed:
August 3, 2018
Date of Patent:
March 2, 2021
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Matthew Reedy, Randall B Pugh, Derek Nankivil, Pere Ventura, Ross Franklin, Adam Toner
Abstract: Described are polymerizable high energy light absorbing compounds. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.
Abstract: Designs, apparatus and methods to form contact lenses with aesthetic elements on demand are described. In some examples, the method of defining the aesthetic aspect includes printing patterns. Other examples include photochromic or thermochromic elements which may provide patterning on exposure to electromagnetic irradiation. In some further examples, energized components in contact lenses may provide aesthetic characteristics.
Abstract: This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.
Type:
Grant
Filed:
April 3, 2020
Date of Patent:
March 2, 2021
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Kevin P. McCabe, Frank F. Molock, Jr., Gregory A. Hill, Azaam Alli, Robert B. Steffen, Douglas G. Vanderlaan, James D. Ford
Abstract: Lenses are designed using the corneal topography or wavefront measurements of the eye derived by subtracting the optical power of the eye after orthokeratology treatment from the optical power before orthokeratology treatment.
Type:
Grant
Filed:
May 30, 2018
Date of Patent:
February 23, 2021
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Michael J. Collins, Brett A. Davis, Khaled A. Chehab, Xu Cheng, Daoud Robert Iskander
Abstract: A system, method and computer program product for estimating future axial elongation of an individual's eye as a way to predict and track refractive error progression of an individual. The method includes: receiving, via a computer interface, data relating to refractive change in a prior pre-determined time period for the individual from a reference timepoint; receiving data representing an age of the individual and data representing a current axial length value of the eye as measured at the reference timepoint; calculating, by said processor, a future axial elongation of the eye as a function of the age of the individual, the current axial length value of the eye as measured at the reference timepoint, and the refractive change in the prior pre-determined time period; generating, an output indication of said computed axial elongation of the eye, and using said output indication to select a myopia control treatment for said individual.
Abstract: This invention discloses apparatus for generating an ophthalmic lens with at least a portion of one surface free-formed from a Reactive Mixture. In some embodiments, an ophthalmic lens is formed on a substrate with an arcuate optical quality surface via a source of actinic radiation controllable to cure a definable portion of a volume of Reactive Mixture.
Type:
Grant
Filed:
January 13, 2020
Date of Patent:
January 26, 2021
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Michael F Widman, John B Enns, P. Mark Powell, Peter W Sites
Abstract: The present invention is related to a contact lens package with a heat sealable multilayer packaging lidstock formed from: a support layer and a peelable seal layer made from a polymer blend, such polymer blend formed from a material: from 40 to 85% by weight of one or more first amorphous cyclic olefin polymer(s) characterized by a glass transition temperature of at least 120° C. from 10 to 55% by weight of one or more second amorphous cyclic olefin polymer(s) characterized by a glass transition temperature of less than 120° C., and from 0.5 to 15% by weight, preferably 0.5 to 10% by weight of at least one elastomeric copolymer comprising at least one polymerized monovinylarene and at least one polymerized acyclic olefin.
Abstract: The present disclosure relates to ophthalmic devices such as ophthalmic lenses. An ophthalmic device may comprise an ophthalmic lens for at least one of slowing, retarding or preventing myopia progression. The ophthalmic lens may comprise a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising an ADD power, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone.
Type:
Grant
Filed:
January 22, 2018
Date of Patent:
January 26, 2021
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Noel A. Brennan, Xu Cheng, Jaclyn V. Hernandez, Michael J. Collins, Brett A. Davis, Fan Yi, Derek Dean Nankivil
Abstract: Disclosed in this specification is a process for manufacturing a thermochromic contact lens. The process includes (1) selecting a photoinitiator that absorbs at a first wavelength and at least one thermochromic dye that displays substantial absorption at the first wavelength when the dye is at a first temperature and exhibits at least an 80% reduction in absorbance at the first wavelength at a second temperature, (2) maintaining the reaction mixture at the second temperature and (3) providing cure light that includes the first wavelength.
Type:
Grant
Filed:
April 10, 2018
Date of Patent:
January 19, 2021
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Donnie J. Duis, Nayiby Alvarez-Carrigan, Holly L. Grammer, Ture Kindt-Larsen, Frank F. Molock, Jr., Jaqunda Patton, Kim Sander Pedersen, Eric R. George
Abstract: Described are silicone hydrogels that are more biocompatible than current ocular materials. The silicone hydrogels are formed from a reactive monomer mixture comprising: a mixture of hydroxyl substituted silicone containing components, at least one polyamide; and at least one hydrophilic monomer. The silicone hydrogels also display a desirable balance of properties, including clarity, oxygen permeability, wettability and desirable protein uptake.
Abstract: Designs, strategies and methods for forming micro-batteries are described. In some examples, ultrasonic welded seals may be used to seal battery chemistry within the micro-battery. In some further examples, the micro-battery is encapsulated by a copper film where at least a portion of the copper film is formed by electroless plating.
Type:
Grant
Filed:
January 29, 2018
Date of Patent:
December 29, 2020
Assignee:
JOHNSON & JOHNSON VISION CARE, INC.
Inventors:
Jean-Francois Audebert, Zachary Kanner, Leonard Pagliaro, Lawrence Edward Weinstein, Serena Peterson, Jonathan Howarth
Abstract: Contact lenses incorporating an array of non-coaxial lenslets with add power that create non-coaxial myopic defocus within the optic zone of the lens may be utilized to prevent and/or slow myopia progression. The positive, non-coaxial lenslets cover about twenty to eighty percent of the central pupil area to deliver positive foci of light in front of the retina to slow the rate of myopia progression.
Type:
Grant
Filed:
June 23, 2015
Date of Patent:
December 29, 2020
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Manwai Charis Lau, Noel Brennan, Khaled Chehab, Xu Cheng, Michael Collins, Brett Davis, Eric R. Ritchey, Fan Yi
Abstract: Provided are compositions comprising a block copolymer of the following formula: [A]-B-[Q], wherein [A] is a polymer that has an affinity for a substrate; B is a linking group comprising an optionally-substituted, polyvalent linking group having a molecular weight of no more than 1000 g/mole; and [Q] comprises a semi-crosslinked, ungelled polymer derived from copolymerization of an ethylenically unsaturated monomer with a poly-functional ethylenically unsaturated monomer. Such block copolymers are cross-linked via the [Q] segment, but not macroscopically gelled. The [Q] segment is hydrophilic and has a degree of polymerization in the range of about 10 to about 10,000. The [A] segment is located on at least one terminal end of said block copolymer, comprises between about 1 and about 200 repeating units. The block copolymer is associated, via the linear substrate associative segment with a surface comprising at least one hydrophobic site, such as a silicone hydrogel.
Type:
Grant
Filed:
October 22, 2019
Date of Patent:
December 22, 2020
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Charles W. Scales, Kevin P. McCabe, Brent Matthew Healy
Abstract: Ophthalmic lenses incorporate multifocal properties for the purpose of slowing, retarding, controlling or preventing myopia development or progression, correcting presbyopic vision or allowing extended depth of focus. The lens has electronically controlled adjustable focus where the change in focus oscillates so rapidly that it is imperceptible to human vision.
Type:
Grant
Filed:
March 15, 2017
Date of Patent:
December 8, 2020
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Noel A. Brennan, Salvatore Caldarise, Khaled Chehab, Xu Cheng, Michael J. Collins, Brett A. Davis, Jaclyn Hernandez, Adam Toner, Fan Yi
Abstract: Methods and apparatuses are disclosed for the diagnosis and removal of the devitalized and/or dead cell material formed in the lid margin to attempt to restore a normal lid margin. In this manner, the devitalized and/or dead cell material are removed or the amount present is reduced or no longer present to prevent, reduce, or affect the transport of lipid secreted by the meibomian glands to the tear film to reduce evaporative dry eye and improve dry eye conditions in patients. The diagnosis and removal of devitalized and/or dead cell material may be performed at desired intervals. Patients that suffer from conditions that block meibomian gland orifices, partial, infrequent, or inhibited blinking resulting in reduced lipid secretions from meibomian glands, and/or blockages in meibomian gland channels reducing secretion of lipids through the meibomian gland orifices may require more frequent diagnosis and treatment to remove devitalized and/or dead cell material.
Type:
Grant
Filed:
August 22, 2013
Date of Patent:
November 24, 2020
Assignee:
Johnson & Johnson Vision Care, Inc.
Inventors:
Donald R. Korb, Steve Bacich, Caroline Blackie, Stephen M. Grenon
Abstract: Contact lenses incorporate high plus or add power profiles that at least one of slow, retard or preventing myopia progression and minimize halo effect. The lens includes a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile that increases from an outer margin of the center zone to a positive power within the at least one treatment zone of greater than +5.00 D.
Type:
Grant
Filed:
May 24, 2019
Date of Patent:
November 17, 2020
Assignee:
Johnson & Johnson Vision Care, Inc
Inventors:
Noel A. Brennan, Khaled Chehab, Xu Cheng, Michael J. Collins, Manwai Charis Lau, Eric R. Ritchey, Xin Wei
Abstract: The present disclosure relates to sensor systems for electronic ophthalmic devices. In certain embodiments, the sensor systems may comprise a selection layer configured to reject light from the eye within a first range of incident angles and allow light from the eye within a second range of incident angles to pass through the selection layer. The sensor system may comprise a plurality of photodiodes disposed below the selection layer and configured to detect the light from the eye within the second range of incident angles that is allowed to pass through the selection layer. The sensor system may comprise an output circuit electrically coupled to the plurality of photodiodes and configured to output a signal indicative of which photodiode of the plurality of photodiodes detected the light.